NIH-funded research R01 grant

Understanding how certain proteins help cells change their function

Official title: Role of nucleosome architecture in cellular reprogramming

Funded at University of North Dakota · NIH-10907409 · Data updated 2026-11-12

This study is looking at how certain proteins help change the way DNA works in our cells, which could help us understand how to reprogram cells and find better treatments for diseases like cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of North Dakota
NIH-funded
Lab location1 site (Grand Forks, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$296,100
NIH project number5R01GM148729-02
Project IDNIH-10907409 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to misregulation of pioneer factors, such as certain types of cancer.

Less likely to help

Patients with conditions unrelated to cellular reprogramming or pioneer factor misregulation may not benefit from this research.

What this research studies

This research investigates how specific proteins, known as pioneer factors, interact with the structure of DNA to enable cells to change their function. By examining how these proteins can modify the physical barriers of DNA, the study aims to uncover the mechanisms that allow for effective gene activation. The research employs advanced techniques, including CRISPR, to manipulate and observe these interactions in a controlled environment. This could provide insights into how cells can be reprogrammed, which is crucial for understanding various diseases, including cancer.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating diseases by improving our ability to reprogram cells.

How similar studies have gone: Other research has shown promise in understanding the role of pioneer factors in cellular reprogramming, indicating that this approach has potential for significant breakthroughs.

Where this research is happening

  • University of North Dakota
    Grand Forks, United States
    Active

Researchers

  • Principal investigator: Takaku, Motoki — University of North Dakota
  • Study coordinator: Takaku, Motoki

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.